Analysis of Drug-Resistance Characteristics and Genetic Diversity of Multidrug-Resistant Tuberculosis Based on Whole-Genome Sequencing on the Hainan Island, China
Jieying Wang,Chunchun Yu,Yuni Xu,Zhuolin Chen,Wenhua Qiu,Shaowen Chen,Hua Pei,Yeteng Zhong
DOI: https://doi.org/10.2147/IDR.S423955
2023-09-05
Infection and Drug Resistance
Abstract:Jieying Wang, &ast Chunchun Yu, &ast Yuni Xu, &ast Zhuolin Chen, Wenhua Qiu, Shaowen Chen, Hua Pei, Yeteng Zhong Department of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570216, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yeteng Zhong, Department of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570216, People's Republic of China, Email Purpose: Given the high burden of Tuberculosis (TB) in China, the prevalence of multidrug-resistant tuberculosis (MDR-TB) is significant. Whole-genome sequencing (WGS) of Mycobacterium tuberculosis (MTB) enables the identification of lineages, drug-resistant mutations, and transmission patterns, offering valuable insights for TB control, clinical diagnosis, and treatment. Methods: We collected 202 MDR-MTB strains from 3519 suspected pulmonary TB patients treated at The Second Affiliated Hospital of Hainan Medical University between July 2019 and June 2021. Proportional drug-susceptibility testing was performed using 8 common anti-tuberculosis drugs. Subsequently, the genotypic drug resistance and genetic characteristics were analyzed by the WGS. Results: Lineages are identified by TB-profiler revealed 202 MDR-MTB strains, showcasing three predominant lineages, with lineage 2 being the most prevalent. Close genomic relatedness analysis and evidence of MTB transmission led to the formation of 15 clusters comprising 42 isolates, resulting in a clustering rate of 20.8%. Novelty, lineage 2.1 (non-Beijing) accounted for 27.2% of the MDR-MTB strains, which is rare in China and Neighboring countries. Regarding first-line anti-TB drugs, genes associated with rifampicin resistance, primarily the rpoB gene, were detected in 200 strains (99.0%). Genes conferring resistance to isoniazid, ethambutol, and streptomycin were identified in 191 (94.5%), 125 (61.9%), and 100 (49.5%) strains, respectively. Among the second-line drugs, 97 (48.0%) strains exhibited genes encoding resistance to fluoroquinolones. Comparing the results to phenotypic drug susceptibility-based testing, the sensitivity of WGS for detecting resistance to each of the six drugs (rifampicin, isoniazid, ethambutol, ofloxacin, kanamycin, capreomycin) was 90% or higher. With the exception of ethambutol, the specificity of WGS prediction for the remaining drugs exceeded 88%. Conclusion: Our study provides crucial insights into genetic mutation types, genetic diversity, and transmission of MDR-MTB on Hainan Island, serving as a significant reference for MDR-MTB surveillance and clinical decision-making. Keywords: tuberculosis, MDR-TB, whole-genome sequencing, WGS, genetic diversity, Hainan Island, China Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), continues to pose a significant global public health challenge. 1–3 In 2021, there were 10.6 million new TB cases worldwide, with China accounting for 780,000 cases, making it the third highest burden country for TB globally. 4 The World Health Organization (WHO) estimates that in 2021, there were 450,000 cases of rifampicin-resistant tuberculosis (RR-TB) globally, of which over 70% were multidrug-resistant tuberculosis (MDR-TB), characterized by resistance to both isoniazid and rifampicin simultaneously. 4 Unfortunately, only one-third of these patients receive appropriate diagnosis and treatment. Given the increased difficulty, cost, and poorer prognosis associated with treating MDR-TB, ongoing vigilance is essential. 5,6 Furthermore, as early diagnosis and appropriate treatment can prevent the majority of TB-related deaths, the rapid and accurate identification of MDR-TB patients is crucial for guiding early clinical interventions and improving cure rates. Since the successful completion of the WGS of MTB H37Rv and its publication in 1998, 7 WGS has found extensive clinical applications, encompassing drug susceptibility prediction, epidemiological analysis, and transmission dynamics research. 8 WGS enables the detection of transmission events missed by epidemiological investigations, differentiation between recurrent TB and reinfection, and more reliable classification of MTB lineages and sub-lineages. 9 Moreover, it offers a comprehensive assessment of pathogen drug resistance profiles. 10–12 TB incidence in China displays regional disparities, with substantial variations in the degree and pattern of drug resistance across different areas. 13 Hainan Island, comprising four provinces and fifteen counties, is home to an estimated population of 10. -Abstract Truncated-
pharmacology & pharmacy,infectious diseases